| |
|
HCC | Abstract Library |
 |
| |
| The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
|
|
| |
| 2. | Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment |
| |
Nat Commun. 2022 Jul 8;13(1):3964. doi: 10.1038/s41467-022-31312-5.
Kai Markus Schneider # 1 2, Antje Mohs # 1, Wenfang Gui 1, Eric J C Galvez 3, Lena Susanna Candels 1, Lisa Hoenicke 3, Uthayakumar Muthukumarasamy 3, Christian H Holland 4 5, Carsten Elfers 1, Konrad Kilic 1, Carolin Victoria Schneider 1 6, Robert Schierwagen 7 8, Pavel Strnad 1, Theresa H Wirtz 1, Hanns-Ulrich Marschall 9, Eicke Latz 10 11 12, Benjamin Lelouvier 13, Julio Saez-Rodriguez 4 5, Willem de Vos 14 15, Till Strowig 3, Jonel Trebicka 7 8, Christian Trautwein 16
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 7. | Patient-reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver Diseases |
| |
Hepatology. 2022 Jul;76(1):251-274. doi: 10.1002/hep.32313. Epub 2022 Jan 22.
Marina Serper 1 2 3, Neehar D Parikh 4, Grace Thiele 1, Nadia Ovchinsky 5, Shivang Mehta 6, Alexander Kuo 7, Chanda Ho 8, Fasiha Kanwal 9 10 11, Michael Volk 12, Sumeet K Asrani 13, Marwan S Ghabril 14, John R Lake 15, Raphael B Merriman 16, Timothy R Morgan 17, Elliot B Tapper 4 18
|
|
| |
|
|
| |
| 9. | Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial |
| |
Lancet Oncol. 2022 Aug;23(8):995-1008.doi: 10.1016/S1470-2045(22)00326-6. Epub 2022 Jul 4.
Robin Kate Kelley 1, Lorenza Rimassa 2, Ann-Lii Cheng 3, Ahmed Kaseb 4, Shukui Qin 5, Andrew X Zhu 6, Stephen L Chan 7, Tamar Melkadze 8, Wattana Sukeepaisarnjaroen 9, Valery Breder 10, Gontran Verset 11, Edward Gane 12, Ivan Borbath 13, Jose David Gomez Rangel 14, Baek-Yeol Ryoo 15, Tamta Makharadze 16, Philippe Merle 17, Fawzi Benzaghou 18, Kamalika Banerjee 19, Saswati Hazra 19, Jonathan Fawcett 19, Thomas Yau 20
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 22. | HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis |
| |
J Hepatol. 2022 Jul;77(1):128-139. doi: 10.1016/j.jhep.2022.01.023.Epub 2022 Feb 6.
Amit G Singal 1, Emily Zhang 2, Manasa Narasimman 2, Nicole E Rich 2, Akbar K Waljee 3, Yujin Hoshida 2, Ju Dong Yang 4, Maria Reig 5, Giuseppe Cabibbo 6, Pierre Nahon 7, Neehar D Parikh 3, Jorge A Marrero 8
|
|
| |
|
|
| |
| 24. | Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial |
| |
Clin Cancer Res. 2022 Jun 13;28(12):2547-2554.doi: 10.1158/1078-0432.CCR-21-3807
Gontran Verset 1, Ivan Borbath 2, Mark Karwal 3, Chris Verslype 4, Hans Van Vlierberghe 5, Adel Kardosh 6, Vittorina Zagonel 7, Per Stal 8, Debashis Sarker 9, Daniel H Palmer 10, Arndt Vogel 11, Julien Edeline 12, Stephane Cattan 13, Masatoshi Kudo 14, Ann-Lii Cheng 15, Sadahisa Ogasawara 16, Bruno Daniele 17, Stephen L Chan 18, Jennifer J Knox 19, Shukui Qin 20, Abby B Siegel 21, Michael Chisamore 21, Ken Hatogai 21, Anran Wang 21, Richard S Finn # 22, Andrew X Zhu # 23 24
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 36. | Prognostic and Predictive Factors in Patients with Advanced HCC and Elevated Alpha-Fetoprotein Treated with Ramucirumab in Two Randomized Phase III Trials |
| |
Clin Cancer Res. 2022 Jun 1;28(11):2297-2305.doi: 10.1158/1078-0432.CCR-21-4000.
Josep M Llovet 1 2 3, Amit G Singal 4, Augusto Villanueva 1, Richard S Finn 5, Masatoshi Kudo 6, Peter R Galle 7, Masafumi Ikeda 8, Sophie Callies 9, Louise M McGrath 9, Chunxiao Wang 9, Paolo Abada 9, Ryan C Widau 9, Elena Gonzalez-Gugel 9, Andrew X Zhu 10 11
|
|
| |
|
|
| |
| 38. | The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis |
| |
Hepatol Commun. 2022 May;6(5):1213-1226. doi: 10.1002/hep4.1886.Epub 2021 Dec 27.
Hamish Innes 1 2 3, Hans Dieter Nischalke 4, Indra Neil Guha 5, Karl Heinz Weiss 6, Will Irving 5, Daniel Gotthardt 7, Eleanor Barnes 8, Janett Fischer 9, M Azim Ansari 8, Jonas Rosendahl 10, Shang-Kuan Lin 8, Astrid Marot 11 12, Vincent Pedergnana 13, Markus Casper 14, Jennifer Benselin 5, Frank Lammert 14, John McLauchlan 15, Philip L Lutz 4, Victoria Hamill 1 3, Sebastian Mueller 16 17, Joanne R Morling 2 5, Georg Semmler 18 19, Florian Eyer 20, Johann von Felden 21, Alexander Link 22, Arndt Vogel 23, Jens U Marquardt 24, Stefan Sulk 25, Jonel Trebicka 26 27, Luca Valenti 28 29, Christian Datz 19, Thomas Reiberger 18, Clemens Schafmayer 30, Thomas Berg 9, Pierre Deltenre # 11 31 32, Jochen Hampe # 25 33, Felix Stickel # 34, Stephan Buch # 25
|
|
| |
| 39. | Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis |
| |
J Gastrointest Cancer. 2022 May 30
Gauri Mishra 1 2, Ammar Majeed 3 4, Anouk Dev 5 3, Guy D Eslick 6, David J Pinato 7, Hirofumi Izumoto, Atsushi Hiraoka 8, Teh-Ia Huo 9 10, Po-Hong Liu 11, Philip J Johnson 12, Stuart K Roberts 3 4
|
|
| |
| 40. | Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis: HCC and Steatosis or Steatohepatitis |
| |
Neoplasia. 2022 Aug;30:100809. doi: 10.1016/j.neo.2022.100809.Epub 2022 May 27.
Fausto Petrelli 1, Michele Manara 2, Silvia Colombo 3, Gabriella De Santi 2, Michele Ghidini 4, Marco Mariani 2, Alessandro Iaculli 5, Emanuele Rausa 6, Valentina Rampulla 2, Marcella Arru 2, Matteo Viti 2, Veronica Lonati 7, Antonio Ghidini 8, Andrea Luciani 7, Antonio Facciorusso 9
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 47. | Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib |
| |
Eur J Cancer. 2022 May;167:1-12. doi: 10.1016/j.ejca.2022.02.009.Epub 2022 Mar 29.
Masatoshi Kudo 1, Richard S Finn 2, Julien Edeline 3, Stéphane Cattan 4, Sadahisa Ogasawara 5, Daniel H Palmer 6, Chris Verslype 7, Vittorina Zagonel 8, Laetitia Fartoux 9, Arndt Vogel 10, Debashis Sarker 11, Gontran Verset 12, Stephen L Chan 13, Jennifer Knox 14, Bruno Daniele 15, Thomas Yau 16, Ellen B Gurary 17, Abby B Siegel 18, Anran Wang 19, Ann-Lii Cheng 20, Andrew X Zhu 21, KEYNOTE-224 Investigators
|
|
| |
|
|
| |
|
|
| |
| 50. | BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update |
| |
J Hepatol. 2022 Mar;76(3):681-693. doi: 10.1016/j.jhep.2021.11.018.Epub 2021 Nov 19.
Maria Reig 1, Alejandro Forner 2, Jordi Rimola 3, Joana Ferrer-Fàbrega 4, Marta Burrel 5, Ángeles Garcia-Criado 3, Robin K Kelley 6, Peter R Galle 7, Vincenzo Mazzaferro 8, Riad Salem 9, Bruno Sangro 10, Amit G Singal 11, Arndt Vogel 12, Josep Fuster 13, Carmen Ayuso 14, Jordi Bruix 15
|
|
| |
| 51. | Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial |
| |
Lancet Gastroenterol Hepatol. 2022 Mar;7(3):208-218.doi: 10.1016/S2468-1253(21)00427-1. Epub 2022 Jan 20.
Ahmed Omar Kaseb 1, Elshad Hasanov 2, Hop Sanderson Tran Cao 3, Lianchun Xiao 4, Jean-Nicolas Vauthey 3, Sunyoung S Lee 5, Betul Gok Yavuz 5, Yehia I Mohamed 5, Aliya Qayyum 6, Sonali Jindal 7, Fei Duan 7, Sreyashi Basu 7, Shalini S Yadav 7, Courtney Nicholas 7, Jing Jing Sun 7, Kanwal Pratap Singh Raghav 5, Asif Rashid 8, Kristen Carter 5, Yun Shin Chun 3, Ching-Wei David Tzeng 3, Divya Sakamuri 5, Li Xu 5, Ryan Sun 4, Vittorio Cristini 9, Laura Beretta 10, James C Yao 5, Robert A Wolff 5, James Patrick Allison 11, Padmanee Sharma 12
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 57. | Nivolumab versus sorafenib in advanced hepatocellular carcinoma |
| |
Lancet Oncol. 2022 Jan;23(1):77-90. doi: 10.1016/S1470-2045(21)00604-5.Epub 2021 Dec 13.
(CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
Thomas Yau 1, Joong-Won Park 2, Richard S Finn 3, Ann-Lii Cheng 4, Philippe Mathurin 5, Julien Edeline 6, Masatoshi Kudo 7, James J Harding 8, Philippe Merle 9, Olivier Rosmorduc 10, Lucjan Wyrwicz 11, Eckart Schott 12, Su Pin Choo 13, Robin Kate Kelley 14, Wolfgang Sieghart 15, Eric Assenat 16, Renata Zaucha 17, Junji Furuse 18, Ghassan K Abou-Alfa 8, Anthony B El-Khoueiry 19, Ignacio Melero 20, Damir Begic 21, Gong Chen 21, Jaclyn Neely 21, Tami Wisniewski 21, Marina Tschaika 21, Bruno Sangro 22
|
|
| |
| 58. | Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis |
| |
Gut. 2022 Mar;71(3):593-604. doi: 10.1136/gutjnl-2020-323663.Epub 2021 Mar 19.
Victor Sapena # 1, Marco Enea # 2, Ferran Torres # 3 4, Ciro Celsa # 2 5, Jose Rios 3 4, Giacomo Emanuele Maria Rizzo 2, Pierre Nahon 6, Zoe Mariño 7, Ryosuke Tateishi 8, Tatsuya Minami 8, Angelo Sangiovanni 9 10, Xavier Forns 7, Hidenori Toyoda 11, Stefano Brillanti 12, Fabio Conti 12, Elisabetta Degasperi 9 10, Ming-Lung Yu 13 14, Pei-Chien Tsai 13, Kevin Jean 15 16, Mohamed El Kassas 17, Hend Ibrahim Shousha 18, Ashraf Omar 18, Claudio Zavaglia 19, Hiroko Nagata 20, Mina Nakagawa 21 22, Yasuhiro Asahina 23, Amit G Singal 24, Caitlin Murphy 24, Mohamed Kohla 25, Chiara Masetti 26, Jean-François Dufour 27 28, Nicolas Merchante 29, Luisa Cavalletto 30, Liliana Lc Chemello 30, Stanislas Pol 31, Javier Crespo 32 33, Jose Luis Calleja 34 35, Rosanna Villani 36, Gaetano Serviddio 36, Alberto Zanetto 37, Sarah Shalaby 37, Francesco Paolo Russo 37, Rob Bielen 38 39, Franco Trevisani 40, Calogero Cammà 2, Jordi Bruix 1, Giuseppe Cabibbo 41, Maria Reig 42
|
|
| |
| 59. | Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial |
| |
Lancet Gastroenterol Hepatol. 2022 Mar;7(3):219-229.doi: 10.1016/S2468-1253(21)00385-X. Epub 2022 Jan 20.
Thomas U Marron 1, Maria Isabel Fiel 2, Pauline Hamon 3, Nathalie Fiaschi 4, Edward Kim 5, Stephen C Ward 2, Zhen Zhao 6, Joel Kim 3, Paul Kennedy 7, Ganesh Gunasekaran 8, Parissa Tabrizian 8, Deborah Doroshow 9, Meredith Legg 9, Ashley Hammad 9, Assaf Magen 3, Alice O Kamphorst 10, Muhammed Shareef 11, Namita T Gupta 4, Raquel Deering 4, Wei Wang 4, Fang Wang 4, Pradeep Thanigaimani 4, Jayakumar Mani 4, Leanna Troncoso 3, Alexandra Tabachnikova 3, Christie Chang 3, Guray Akturk 12, Mark Buckup 3, Steven Hamel 12, Giorgio Ioannou 12, Clotilde Hennequin 3, Hajra Jamal 3, Haley Brown 3, Antoinette Bonaccorso 13, Daniel Labow 8, Umut Sarpel 8, Talia Rosenbloom 14, Max W Sung 15, Baijun Kou 4, Siyu Li 4, Vladimir Jankovic 4, Nicola James 4, Sara C Hamon 4, Hung Kam Cheung 4, Jennifer S Sims 4, Elizabeth Miller 4, Nina Bhardwaj 16, Gavin Thurston 4, Israel Lowy 4, Sacha Gnjatic 17, Bachir Taouli 18, Myron E Schwartz 19, Miriam Merad 20
|
|
| |
| 60. | . Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma |
| |
J Hepatol. 2022 Apr;76(4):862-873.doi: 10.1016/j.jhep.2021.11.030. Epub 2021 Dec 11
Ann-Lii Cheng 1, Shukui Qin 2, Masafumi Ikeda 3, Peter R Galle 4, Michel Ducreux 5, Tae-You Kim 6, Ho Yeong Lim 7, Masatoshi Kudo 8, Valeriy Breder 9, Philippe Merle 10, Ahmed O Kaseb 11, Daneng Li 12, Wendy Verret 13, Ning Ma 14, Alan Nicholas 15, Yifan Wang 16, Lindong Li 17, Andrew X Zhu 18, Richard S Finn 19
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 66. | Safety and Efficacy of Transarterial Chemoembolization in Elderly Patients with Intermediate Hepatocellular Carcinoma |
| |
Cancers (Basel). 2022 Mar 23;14(7):1634. doi: 10.3390/cancers14071634.
Gael S Roth 1 2 3, Olivier Hernandez 2, Najeh Daabek 4 5, Bleuenn Brusset 2, Yann Teyssier 1 6, Julien Ghelfi 1 3 6, Marie Noelle Hilleret 2, Christian Sengel 6, Ivan Bricault 1 6, Thomas Decaens 1 2 3, Charlotte Costentin 1 2 3
|
|
| |
|
|
| |
|
|
| |
| 69. | Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience |
| |
Ther Adv Med Oncol. 2022 Feb 26;14:17588359221080298. doi: 10.1177/17588359221080298.eCollection 2022.
Tiago de Castro 1, Leonie S Jochheim 2, Melanie Bathon 1, Sabrina Welland 1, Bernhard Scheiner 3, Kateryna Shmanko 4, Daniel Roessler 5, Najib Ben Khaled 5, Matthias Jeschke 2, Johannes M Ludwig 6, Jens U Marquardt 7, Arndt Weinmann 4, Matthias Pinter 3, Christian M Lange 2, Arndt Vogel 8, Anna Saborowski 1
|
|
| |
| 70. | Liver function after combined selective internal radiation therapy or sorafenib monotherapy in advanced hepatocellular carcinoma |
| |
J Hepatol. 2021 Dec;75(6):1387-1396. doi: 10.1016/j.jhep.2021.07.037.Epub 2021 Aug 27.
Jens Ricke 1, Regina Schinner 2, Max Seidensticker 2, Antonio Gasbarrini 3, Otto M van Delden 4, Holger Amthauer 5, Bora Peynircioglu 6, Irene Bargellini 7, Roberto Iezzi 8, Enrico N De Toni 9, Peter Malfertheiner 10, Maciej Pech 11, Bruno Sangro 12
|
|
| |
|
|
| |
| 72. | Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression |
| |
Clin Gastroenterol Hepatol. 2022 Feb;20(2):283-292.e10.doi: 10.1016/j.cgh.2021.05.002. Epub 2021 May 28.
Lorenzo A Orci 1, Marco Sanduzzi-Zamparelli 2, Berta Caballol 3, Victor Sapena 3, Nicola Colucci 4, Ferran Torres 5, Jordi Bruix 3, María Reig 6, Christian Toso 7
|
|
| |
| 73. | Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade |
| |
Br J Cancer. 2022 Mar;126(4):569-575. doi: 10.1038/s41416-021-01532-5.Epub 2021 Oct 7.
Robin Kate Kelley # 1, Rebecca Miksad # 2 3 4, Irfan Cicin 5, YenHsun Chen 6, Heinz-Josef Klümpen 7, Stefano Kim 8, Zhong-Zhe Lin 9, Jillian Youkstetter 10, Saswati Hazra 10, Suvajit Sen 10, Ann-Lii Cheng 9, Anthony B El-Khoueiry 11, Tim Meyer 12, Ghassan K Abou-Alfa 13 14
|
|
| |
|
|
| |
| 75. | Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial |
| |
J Cancer Res Clin Oncol. 2022 Feb;148(2):475-485.doi: 10.1007/s00432-021-03627-1. Epub 2021 Apr 14.
Osman Öcal 1, Kerstin Schütte 2, Juozas Kupcinskas 3, Egidijus Morkunas 3, Gabija Jurkeviciute 3, Enrico N de Toni 4, Najib Ben Khaled 4, Thomas Berg 5, Peter Malfertheiner 4, Heinz Josef Klümpen 6, Christian Sengel 7, Bristi Basu 8, Juan W Valle 9, Julia Benckert 10, Antonio Gasbarrini 11, Daniel Palmer 12, Ricarda Seidensticker 1, Moritz Wildgruber 1, Bruno Sangro 13, Maciej Pech 14, Jens Ricke 1, Max Seidensticker 15
|
|
| |
|
|
| |
|
|
| |
| 78. | Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study |
| |
Hepatology. 2022 Mar 21. doi: 10.1002/hep.32468. Online ahead of print.
Antonio D'Alessio 1 2, Claudia Angela Maria Fulgenzi 1 3, Naoshi Nishida 4, Martin Schönlein 5, Johann von Felden 6, Kornelius Schulze 6, Henning Wege 6, Vincent E Gaillard 7, Anwaar Saeed 8, Brooke Wietharn 8, Hannah Hildebrand 8, Linda Wu 9, Celina Ang 9, Thomas U Marron 9, Arndt Weinmann 10, Peter R Galle 10, Dominik Bettinger 11, Bertram Bengsch 11 12 13, Arndt Vogel 14, Lorenz Balcar 15, Bernhard Scheiner 15, Pei-Chang Lee 16, Yi-Hsiang Huang 16 17, Suneetha Amara 18, Mahvish Muzaffar 18, Abdul Rafeh Naqash 18 19, Antonella Cammarota 2 20, Nicola Personeni 2 20, Tiziana Pressiani 20, Rohini Sharma 1, Matthias Pinter 15, Alessio Cortellini 1, Masatoshi Kudo 4, Lorenza Rimassa 2 20, David J Pinato 1 21
|
|
| |
| 79. | T cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma |
| |
J Hepatol. 2022 Mar 31;S0168-8278(22)00180-5. doi: 10.1016/j.jhep.2022.02.032.Online ahead of print.
Maryam Barsch 1, Henrike Salié 1, Alexandra Emilia Schlaak 1, Zhen Zhang 1, Moritz Hess 2, Lena Sophie Mayer 1, Catrin Tauber 1, Patricia Otto-Mora 1, Takuya Ohtani 3, Tobias Nilsson 1, Lara Wischer 1, Frances Winkler 1, Sasikant Manne 3, Andrew Rech 3, Annette Schmitt-Graeff 4, Peter Bronsert 4, Maike Hofmann 1, Christoph Neumann-Haefelin 1, Tobias Boettler 1, Stefan Fichtner-Feigl 5, Florian van Boemmel 6, Thomas Berg 6, Lorenza Rimassa 7, Luca Di Tommaso 8, Anwaar Saeed 9, Antonio D'Alessio 10, David J Pinato 11, Dominik Bettinger 1, Harald Binder 2, E John Wherry 3, Michael Schultheiss 1, Robert Thimme 1, Bertram Bengsch 12
|
|
| |
| 80. | The largest western experience on salvage hepatectomy for recurrent hepatocellular carcinoma: propensity score-matched analysis on behalf of He.RC.O.Le.Study Group |
| |
HPB (Oxford). 2022 Jan 11;S1365-182X(22)00001-6. doi: 10.1016/j.hpb.2022.01.001.Online ahead of print.
Maurizio Iaria 1, Giorgio Bianchi 2, Federico Fazio 3, Francesco Ardito 4, Pasquale Perri 5, Nicholas Pontarolo 6, Simone Conci 7, Matteo Donadon 8, Matteo Zanello 9, Quirino Lai 10, Simone Famularo 11, Sarah Molfino 12, Ivano Sciannamea 13, Luca Fumagalli 14, Paola Germani 15, Antonio Floridi 16, Cecilia Ferrari 17, Giuseppe Zimmitti 18, Albert Troci 19, Mauro Zago 20, Valentina Ferraro 21, Federica Cipriani 22, Stefan Patauner 23, Giuliano La Barba 24, Maurizio Romano 25, Giacomo Zanus 25, Giorgio Ercolani 26, Antonio Frena 23, Luca Aldrighetti 22, Riccardo Memeo 21, Enrico Pinotti 27, Michele Crespi 19, Moh'd Abu Hilal 18, Guido Griseri 17, Paola Tarchi 15, Marco Chiarelli 14, Adelmo Antonucci 13, Gian L Baiocchi 12, Fabrizio Romano 28, Massimo Rossi 10, Elio Jovine 9, Guido Torzilli 8, Andrea Ruzzenente 7, Marcello Maestri 6, Gian L Grazi 5, Felice Giuliante 4, Alessandro Ferrero 3, Raffaele Dalla Valle 2, HE.RC.O.LE.S. GROUP
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 89. | Are Current National Review Board Downstaging Protocols for Hepatocellular Carcinoma Too Restrictive? |
| |
J Am Coll Surg. 2022 Apr 1;234(4):579-588. doi: 10.1097/XCS.0000000000000140.
Ola Ahmed 1, Neeta Vachharajani 1, Kris P Croome 2, Parissa Tabrizian 3, Vatche Agopian 4, Karim Halazun 5, Johnny C Hong 6, Leigh Anne Dageforde 7, William C Chapman 1, Mb Majella Doyle 1, Primary Liver Tumor Study Group
Primary Liver Tumor Study Group: Erin Maynard 8, Yikyung Park 9, Su-Hsin Chang 9, Adeel S Khan 10
|
|
| |
| 90. | UNOS Down-staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 Studies |
| |
Clin Gastroenterol Hepatol. 2022 Feb 15;S1542-3565(22)00144-6.doi: 10.1016/j.cgh.2022.02.018. Online ahead of print.
Darren Jun Hao Tan 1, Wen Hui Lim 2, Jie Ning Yong 2, Cheng Han Ng 2, Mark D Muthiah 3, Eunice X Tan 3, Jieling Xiao 2, Snow Yunni Lim 2, Ansel Shao Pin Tang 2, Xin Hui Pan 2, Tousif Kabir 4, Glenn K Bonney 5, Raghav Sundar 6, Nicholas Syn 7, Beom Kyung Kim 8, Yock Young Dan 9, Mazen Noureddin 10, Rohit Loomba 11, Daniel Q Huang 12
|
|
| |
|
|
| |
|
|
| |
| 93. | Risk Factors for Hepatocellular Cancer in Contemporary Cohorts of Patients with Cirrhosis |
| |
Hepatology. 2022 Mar 1. doi: 10.1002/hep.32434. Online ahead of print.
Fasiha Kanwal 1 2 3, Saira Khaderi 1, Amit G Singal 4, Jorge A Marrero 4, Nicole Loo 5, Sumeet K Asrani 6, Christopher I Amos 7, Aaron P Thrift 7, Xiangjun Gu 7, Michelle Luster 1, Abeer Al-Sarraj 1 2 3, Jing Ning 8, Hashem B El-Serag 1 2 3
|
|
| |
|
|
| |
|
|
| |
| 96. | Incidence and Mortality of Cancers of the Biliary Tract, Gallbladder, and Liver by Sex, Age, Race/Ethnicity, and Stage at Diagnosis: United States, 2013 to 2017 |
| |
Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1607-1614.doi: 10.1158/1055-9965.EPI-21-0265. Epub 2021 Jul
Taylor D Ellington 1 2, Behnoosh Momin 2, Reda J Wilson 2, S Jane Henley 2, Manxia Wu 2, A Blythe Ryerson 3
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 100. | Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment |
| |
Cardiovasc Intervent Radiol. 2022 Feb 4. doi: 10.1007/s00270-021-03031-9.Online ahead of print.
Josep M Llovet 1 2 3, Arndt Vogel 4, David C Madoff 5, Richard S Finn 6, Sadahisa Ogasawara 7, Zhenggang Ren 8, Kalgi Mody 9, Jerry J Li 10, Abby B Siegel 10, Leonid Dubrovsky 10, Masatoshi Kudo 11
|
|
| |
|
|
| |
| 102. | Survival Analysis Using ALBI Grade for Patients Treated with DEE-TACE for Hepatocellular Carcinoma |
| |
J Vasc Interv Radiol. 2022 Feb 9;S1051-0443(22)00061-6. doi: 10.1016/j.jvir.2022.02.005.Online ahead of print.
Lindsay B Young 1, Parissa Tabrizian 1, Jeffrey Sung 2, Derek Biederman 3, Vivian L Bishay 1, Mona Ranade 4, Rahul S Patel 1, Francis S Nowakowski 1, Aaron M Fischman 1, Robert A Lookstein 1, Edward Kim 1
|
|
| |
| 103. | A Novel Blood-Based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular Carcinoma |
| |
Clin Gastroenterol Hepatol. 2021 Dec;19(12):2597-2605.e4.doi: 10.1016/j.cgh.2020.08.065. Epub 2020 Sep 2.
Naga P Chalasani 1, Tiruvidaimarudur S Ramasubramanian 2, Abhik Bhattacharya 2, Marilyn C Olson 2, David K Edwards V 3, Lewis R Roberts 4, John B Kisiel 4, K Rajender Reddy 5, Graham P Lidgard 3, Scott C Johnson 3, Janelle J Bruinsma 2
|
|
| |
| 104. | Hepatectomy for Solitary Hepatocellular Carcinoma: Resection Margin Width Does Not Predict Survival |
| |
J Gastrointest Surg. 2021 Jul;25(7):1727-1735. doi: 10.1007/s11605-020-04765-6.Epub 2020 Aug 10.
Theodoros Michelakos # 1, Filippos Kontos # 1, Yurie Sekigami 1, Motaz Qadan 1, Lei Cai 1, Onofrio Catalano 2, Vikram Deshpande 3, Madhukar S Patel 1, Teppei Yamada 1, Nahel Elias 1, Leigh Anne Dageforde 1, Shoko Kimura 1, Tatsuo Kawai 1, Kenneth K Tanabe 1, James F Markmann 1, Heidi Yeh 1, Cristina R Ferrone 4
|
|
| |
|
|
| |
| 106. | Laparoscopic major hepatectomy for hepatocellular carcinoma in elderly patients: a multicentric propensity score based analysis |
| |
Surg Endosc. 2021 Jul;35(7):3642-3652. doi: 10.1007/s00464-020-07843-7. Epub 2020 Aug 3.
Antonella Delvecchio 1, Maria Conticchio 1, Francesca Ratti 2, Maximiliano Gelli 3 4, Ferdinando Massimiliano Anelli 5, Alexis Laurent 6, Giulio Cesare Vitali 7, Paolo Magistri 8, Giacomo Assirati 8, Emanuele Felli 9, Taiga Wakabayashi 9, Patrick Pessaux 9, Tullio Piardi 10 11, Fabrizio Di Benedetto 8, Nicola de'Angelis 6, Javier Briceño-Delgado 5, Rene Adam 4, Daniel Cherqui 4, Luca Aldrighetti 2, Riccardo Memeo 12
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 112. | Association of dietary fat intake and hepatocellular carcinoma among US adults |
| |
Cancer Med. 2021 Oct;10(20):7308-7319. doi: 10.1002/cam4.4256. Epub 2021 Sep 18.
Iman Moussa 1, Rena S Day 2, Ruosha Li 3, Ahmed Kaseb 4, Prasun K Jalal 5, Carrie Daniel-MacDougall 6, Rikita I Hatia 6, Ahmed Abdelhakeem 7, Asif Rashid 8, Yun Shin Chun 9, Donghui Li 4, Manal M Hassan 6
|
|
| |
| 113. | Early Versus Late Hepatocellular Carcinoma Recurrence After Transplantation: Predictive Factors, Patterns, and Long-term Outcome |
| |
Transplantation. 2021 Aug 1;105(8):1778-1790.doi: 10.1097/TP.0000000000003434.
Nada El-Domiaty 1 2, Faouzi Saliba 1, Eric Vibert 1, Vincent Karam 1, Rodolphe Sobesky 1, Wafaa Ibrahim 3, Gabriella Pittau 1, Oriana Ciacio 1, Chady Salloum 1, Khaled Amer 4, Maysaa A Saeed 2, Jihan A Shawky 2, Antonio Sa Cunha 1, Olivier Rosmorduc 1, Daniel Cherqui 1, René Adam 1, Didier Samuel 1
|
|
| |
| 114. | Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study |
| |
Clin Gastroenterol Hepatol. 2021 Jul;19(7):1469-1479.e19.doi: 10.1016/j.cgh.2020.09.027. Epub 2020 Sep 17.
Donghee Kim 1, Nia Adeniji 1, Nyann Latt 2, Sonal Kumar 3, Patricia P Bloom 4, Elizabeth S Aby 5, Ponni Perumalswami 6, Marina Roytman 7, Michael Li 8, Alexander S Vogel 8, Andreea M Catana 9, Kara Wegermann 10, Rotonya M Carr 11, Costica Aloman 12, Vincent L Chen 13, Atoosa Rabiee 14, Brett Sadowski 15, Veronica Nguyen 16, Winston Dunn 17, Kenneth D Chavin 18, Kali Zhou 19, Blanca Lizaola-Mayo 20, Akshata Moghe 21, José Debes 5, Tzu-Hao Lee 10, Andrea D Branch 6, Kathleen Viveiros 8, Walter Chan 8, David M Chascsa 20, Paul Kwo 1, Renumathy Dhanasekaran 22
|
|
| |
|
|
| |
|
|
| |
| 117. | SIRT Compared with DEB-TACE for Hepatocellular Carcinoma: a Real-world Study (the SITAR Study) |
| |
J Gastrointest Cancer. 2021 Sep;52(3):907-914. doi: 10.1007/s12029-020-00502-z.
Ryan D Hirsch 1 2, Chris Mills 3, Rohit Sawhney 4 5, Siddharth Sood 6, Virginia Bird 6, Gauri Mishra 7, Anouk Dev 7, William Kemp 8 9, John Lubel 8 9, Stuart K Roberts 8 9, Paul Gow 3, Amanda J Nicoll 4 5 6
|
|
| |
| 118. | HepatoScore-14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk |
| |
Hepatology. 2021 Jun;73(6):2278-2292. doi: 10.1002/hep.31555. Epub 2021 Jun 15.
Jeffrey S Morris 1, Manal M Hassan 2, Ye Emma Zohner 3, Zeya Wang 3 4, Lianchun Xiao 5, Asif Rashid 6, Abedul Haque 7, Reham Abdel-Wahab 8, Yehia I Mohamed 8, Karri L Ballard 9, Robert A Wolff 8, Bhawana George 7, Liang Li 5, Genevera Allen 3 10, Michael Weylandt 3, Donghui Li 8, Wenyi Wang 4, Kanwal Raghav 8, James Yao 8, Hesham M Amin 7, Ahmed Omar Kaseb 8
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 122. | Charlson comorbidity index and G8 in older old adult(=80 years) hepatocellular carcinoma patients treated with stereotactic body radiotherapy |
| |
J Geriatr Oncol. 2021 Sep;12(7):1100-1103. doi: 10.1016/j.jgo.2021.01.001. Epub 2021 Jan 16.
Mauro Loi 1, Tiziana Comito 2, Ciro Franzese 3, Isacco Desideri 4, Luca Dominici 5, Lorenzo Lo Faro 2, Elena Clerici 2, Davide Franceschini 2, Davide Baldaccini 2, Marco Badalamenti 2, Giacomo Reggiori 2, Francesca Lobefalo 2, Marta Scorsetti 3
|
|
| |
| 123. | Survival inequity in vulnerable populations with early-stage hepatocellular carcinoma: a United States safety-net collaborative analysis |
| |
2021 Jun;23(6):868-876. doi: 10.1016/j.hpb.2020.11.1150. Epub 2020 Dec 29.
Joshua P Kronenfeld 1, Emily L Ryon 1, David Goldberg 2, Rachel M Lee 3, Adam Yopp 4, Annie Wang 5, Ann Y Lee 5, Sommer Luu 6, Cary Hsu 6, Eric Silberfein 6, Maria C Russell 3, Nipun B Merchant 1, Neha Goel 7
|
|
| |
| 124. | Impact of cancer center accreditation on outcomes of patients undergoing resection for hepatocellular carcinoma: A SEER-Medicare analysis |
| |
Am J Surg. 2021 Sep;222(3):570-576. doi: 10.1016/j.amjsurg.2021.01.015. Epub 2021 Jan 13.
Diamantis I Tsilimigras 1, J Madison Hyer 1, Adrian Diaz 1, Dimitrios Moris 1, Alizeh Abbas 1, Mary Dillhoff 1, Jordan M Cloyd 1, Aslam Ejaz 1, Joal D Beane 1, Allan Tsung 1, Timothy M Pawlik 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 141. | Circadian Clock and Liver Cancer |
| |
Cancers (Basel). 2021 Jul 20;13(14):3631. doi: 10.3390/cancers13143631.
María Crespo 1, Magdalena Leiva 1, Guadalupe Sabio 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 148. | Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study |
| |
J Clin Oncol. 2021 Jul 22;JCO2003555. doi: 10.1200/JCO.20.03555. Online ahead of print.
Robin Kate Kelley 1, Bruno Sangro 2, William Harris 3, Masafumi Ikeda 4, Takuji Okusaka 5, Yoon-Koo Kang 6, Shukui Qin 7, David W-M Tai 8, Ho Yeong Lim 9, Thomas Yau 10, Wei-Peng Yong 11, Ann-Lii Cheng 12, Antonio Gasbarrini 13, Silvia Damian 14, Jordi Bruix 15, Mitesh Borad 16, Johanna Bendell 17, Tae-You Kim 18, Nathan Standifer 19, Philip He 20, Mallory Makowsky 20, Alejandra Negro 20, Masatoshi Kudo 21, Ghassan K Abou-Alfa 22 23
|
|
| |
|
|
| |
| 150. | Adiposity, Adulthood Weight Change and Risk of Incident Hepatocellular Carcinoma |
| |
Cancer Prev Res (Phila). 2021 Jul 15;canprevres.0549.2020.doi: 10.1158/1940-6207.CAPR-20-0549. Online ahead of print.
Tracey G Simon 1, Mi Na Kim 2, Xiao Luo 3, Xing Liu 3, Wanshui Yang 4, Yanan Ma 4, Dawn Qingqing Chong 5, Charles S Fuchs 6, Meir J Stampfer 7, Edward L Giovannucci 8, Andrew T Chan 9, Xuehong Zhang 10
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 154. | Comparative Efficacy of Atezolizumab plus Bevacizumab and Other Treatment Options for Patients with Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis |
| |
Liver Cancer. 2021 Jun;10(3):240-248. doi: 10.1159/000515302. Epub 2021 May 6.
Arndt Vogel 1, Lorenza Rimassa 2, Hui-Chan Sun 3, Ghassan K Abou-Alfa 4, Anthony El-Khoueiry 5, David J Pinato 6, Javier Sanchez Alvarez 7, Monica Daigl 7, Panos Orfanos 7, Michael Leibfried 8, Marie-Hélène Blanchet Zumofen 7, Vincent E Gaillard 7, Philippe Merle 9
|
|
| |
| 155. | High rate of complete histopathological response in hepatocellular carcinoma patients after combined transarterial chemoembolization and stereotactic body radiation therapy |
| |
World J Gastroenterol. 2021 Jun 28;27(24):3630-3642.doi: 10.3748/wjg.v27.i24.3630.
Ulrike Bauer 1, Sabine Gerum 2, Falk Roeder 2, Stefan Münch 3, Stephanie E Combs 3, Alexander B Philipp 4, Enrico N De Toni 4, Martha M Kirstein 5, Arndt Vogel 5, Carolin Mogler 6, Bernhard Haller 7, Jens Neumann 8, Rickmer F Braren 9, Marcus R Makowski 9, Philipp Paprottka 10, Markus Guba 11, Fabian Geisler 1, Roland M Schmid 1, Andreas Umgelter 1, Ursula Ehmer
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 159. | Laparoscopic surgery versus radiofrequency ablation for the treatment of single hepatocellular carcinoma =3 cm in the elderly: a propensity score matching analysis |
| |
HPB (Oxford). 2021 Jun 8;S1365-182X(21)00159-3. doi: 10.1016/j.hpb.2021.05.008.Online ahead of print.
Maria Conticchio 1, Antonella Delvecchio 1, Francesca Ratti 2, Maximiliano Gelli 3, Ferdinando M Anelli 4, Alexis Laurent 5, Giulio C Vitali 6, Paolo Magistri 7, Giacomo Assirati 7, Emanuele Felli 8, Taiga Wakabayashi 8, Patrick Pessaux 8, Tullio Piardi 9, Fabrizio Di Benedetto 7, Nicola de'Angelis 5, Delgado F Javier Briceno 4, Antonio G Rampoldi 10, René Adam 11, Daniel Cherqui 11, Luca Aldrighetti 2, Riccardo Memeo 12
|
|
| |
| 160. | Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease etiology |
| |
Liver Int. 2021 Jun 26. doi: 10.1111/liv.14994. Online ahead of print.
Peter R Galle 1, Masatoshi Kudo 2, Josep M Llovet 3 4 5, Richard S Finn 6, Mark Karwal 7, Denis Pezet 8, Tae-You Kim 9, Tsai-Sheng Yang 10, Sara Lonardi 11, Jiri Tomasek 12, Jean-Marc Phelip 13, Yann Touchefeu 14, Su-Jin Koh 15, Guido Stirnimann 16, Kun Liang 17, Kenyon D Ogburn 17, Chunxiao Wang 17, Paolo Abada 17, Ryan C Widau 17, Andrew X Zhu 18 19
|
|
| |
|
|
| |
|
|
| |
| 163. | Limited tumor progression beyond Milan criteria while on the waiting list does not result in unacceptable impairment of survival |
| |
J Hepatol. 2021 Jun 22;S0168-8278(21)00435-9. doi: 10.1016/j.jhep.2021.06.015.Online ahead of print.
Joana Ferrer-Fàbrega 1, Jaime Sampson-Dávila 2, Alejandro Forner 3, Victor Sapena 4, Alba Díaz 5, Ramón Vilana 6, Miquel Navasa 7, Constantino Fondevila 8, Rosa Miquel 9, Carmen Ayuso 6, Juan Carlos García-Valdecasas 8, Jordi Bruix 3, María Reig 3, Josep Fuster 10
|
|
| |
|
|
| |
|
|
| |
| 166. | External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV |
| |
JHEP Rep. 2021 Apr 24;3(4):100298. doi: 10.1016/j.jhepr.2021.100298. eCollection 2021 Aug.
Thierry Poynard 1 2, Jean Marc Lacombe 3, Olivier Deckmyn 4, Valentina Peta 2 4, Sepideh Akhavan 1, Victor de Ledinghen 5, Fabien Zoulim 6, Didier Samuel 7 8, Philippe Mathurin 9, Vlad Ratziu 1 2, Dominique Thabut 1 2, Chantal Housset 2, Hélène Fontaine 10, Stanislas Pol 10, Fabrice Carrat 3
|
|
| |
| 167. | Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma |
| |
ESMO Open. 2021 Jun 15;6(4):100190. doi: 10.1016/j.esmoop.2021.100190. Online ahead of print.
I G Rapposelli 1, S Shimose 2, T Kumada 3, S Okamura 2, A Hiraoka 4, G G Di Costanzo 5, F Marra 6, E Tamburini 7, A Forgione 8, F G Foschi 9, M Silletta 10, S Lonardi 11, G Masi 12, M Scartozzi 13, M Nakano 2, H Shibata 14, K Kawata 15, A Pellino 16, C Vivaldi 12, E Lai 13, A Takata 2, K Tajiri 17, H Toyoda 18, R Tortora 5, C Campani 6, M G Viola 19, F Piscaglia 8, F Conti 9, C A M Fulgenzi 10, G L Frassineti 1, M D Rizzato 20, F Salani 21, G Astara 13, T Torimura 2, M Atsukawa 22, T Tada 23, V Burgio 24, M Rimini 25, S Cascinu 26, A Casadei-Gardini 27
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 171. | Understanding the patient experience in hepatocellular carcinoma: a qualitative patient interview study |
| |
Qual Life Res. 2021 Jun 11. doi: 10.1007/s11136-021-02903-4. Online ahead of print.
Nikunj Patel 1, Joshua Maher 2, Xandra Lie 3, Chad Gwaltney 4, Afsaneh Barzi 5, Mark Karwal 6, Teresa Macarulla 7, Hui-Chuan Sun 8, Jörg Trojan 9, Oren Meyers 10, Christina Workman 11, Shethah Morgan 12, Alejandra Negro 11, Gordon Cohen 11
|
|
| |
| 172. | Evidence-based management of HCC: Systematic review and meta-analysis of randomized controlled trials (2002-2020) |
| |
Gastroenterology. 2021 Jun 11;S0016-5085(21)03119-X. doi: 10.1053/j.gastro.2021.06.008.Online ahead of print.
Philipp K Haber 1, Marc Puigvehí 2, Florian Castet 3, Vennis Lourdusamy 1, Robert Montal 4, Parissa Tabrizian 1, Michael Buckstein 1, Edward Kim 1, Augusto Villanueva 1, Myron Schwartz 1, Josep M Llovet 5
|
|
| |
| 173. | Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase 3 REFLECT Study |
| |
Clin Cancer Res. 2021 Jun 9;clincanres.4219.2020. doi: 10.1158/1078-0432.CCR-20-4219.Online ahead of print.
Richard S Finn 1, Masatoshi Kudo 2, Ann-Lii Cheng 3, Lucjan Wyrwicz 4, Roger Kai-Cheong Ngan 5, Jean-Frederic Blanc 6, Ari D Baron 7, Arndt Vogel 8, Masafumi Ikeda 9, Fabio Piscaglia 10, Kwang-Hyub Han 11, Shu-Kui Qin 12, Yukinori Minoshima 13, Michio Kanekiyo 14, Min Ren 15, Ryo Dairiki 16, Toshiyuki Tamai 17, Corina E Dutcus 18, Hiroki Ikezawa 19, Yasuhiro Funahashi 13, Thomas R Jeffry Evans 20
|
|
| |
|
|
| |
| 175. | Predicting Long-Term Hepatocellular Carcinoma Response to Transarterial Radioembolization Using Contrast-Enhanced Ultrasound: Initial Experiences |
| |
Ultrasound Med Biol. 2021 Jun 12;S0301-5629(21)00218-0.doi: 10.1016/j.ultrasmedbio.2021.05.006. Online ahead of print.
Lauren J Delaney 1, Mohamed Tantawi 1, Corinne E Wessner 1, Priscilla Machado 1, Flemming Forsberg 1, Andrej Lyshchik 1, Patrick O'Kane 1, Ji-Bin Liu 1, Jesse Civan 2, Allison Tan 1, Kevin Anton 1, Colette M Shaw 1, John R Eisenbrey 3
|
|
| |
| 176. | Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients with Cirrhosis |
| |
Clin Gastroenterol Hepatol. 2021 Jun 10;S1542-3565(21)00615-7. doi: 10.1016/j.cgh.2021.06.012.Online ahead of print.
Haley Schoenberger 1, Nicolas Chong 1, David T Fetzer 2, Nicole E Rich 1, Takeshi Yokoo 2, Gaurav Khatri 2, Jocelyn Olivares 3, Neehar D Parikh 4, Adam C Yopp 5, Jorge A Marrero 3, Amit G Singal 6
|
|
| |
|
|
| |
| 178. | Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial |
| |
Lancet Gastroenterol Hepatol. 2021 Jun 1;S2468-1253(21)00110-2.
doi: 10.1016/S2468-1253(21)00110-2. Online ahead of print.
Arndt Vogel 1, Shukui Qin 2, Masatoshi Kudo 3, Yun Su 4, Stacie Hudgens 5, Tatsuya Yamashita 6, Jung-Hwan Yoon 7, Laetitia Fartoux 8, Krzysztof Simon 9, Carlos López 10, Max Sung 11, Kalgi Mody 4, Tatsuroh Ohtsuka 4, Toshiyuki Tamai 4, Lee Bennett 12, Genevieve Meier 4, Valery Breder 13
|
|
| |
| 179. | Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine |
| |
Clin Gastroenterol Hepatol. 2021 Jun 2;S1542-3565(21)00601-7. doi: 10.1016/j.cgh.2021.05.062.Online ahead of print.
Jiyoon Park 1, An K Le 2, Tai-Chung Tseng 3, Ming-Lun Yeh 4, Dae Won Jun 5, Huy Trinh 6, Grace Lh Wong 7, Chien-Hung Chen 8, Cheng-Yuan Peng 9, Sung Eun Kim 10, Hyunwoo Oh 11, Min-Sun Kwak 11, Ka Shing Cheung 12, Hidenori Toyoda 13, Yao-Chun Hsu 14, Jae Yoon Jeong 15, Eileen L Yoon 16, Teerapat Ungtrakul 17, Jian Zhang 18, Qing Xie 19, Sang Bong Ahn 20, Masaru Enomoto 21, Jae-Jun Shim 22, Chris Cunningham 23, Soung Won Jeong 24, Yong Kyun Cho 25, Eiichi Ogawa 26, Rui Huang 27, Dong-Hyun Lee 28, Hirokazu Takahashi 29, Pei-Chien Tsai 4, Chung-Feng Huang 5, Chia-Yen Dai 5, Cheng-Hao Tseng 14, Satoshi Yasuda 13, Ritsuzo Kozuka 21, Jiayi Li 30, Christopher Wong 31, Clifford C Wong 31, Changqing Zhao 32, Joseph Hoang 33, Yuichiro Eguchi 29, Chao Wu 27, Yasuhito Tanaka 34, Ed Gane 35, Tawesak Tanwandee 36, Ramsey Cheung 33, Man-Fung Yuen 12, Hyo-Suk Lee 11, Ming-Lung Yu 4, Jia-Horng Kao 3, Hwai-I Yang 37, Mindie H Nguyen 38
|
|
| |
|
|
| |
| 181. | Skeletal Muscle Volume Is an Independent Predictor of Survival after Sorafenib Treatment Failure for Hepatocellular Carcinoma |
| |
Cancers (Basel). 2021 May 7;13(9):2247. doi: 10.3390/cancers13092247.
Issei Saeki 1, Takahiro Yamasaki 2, Yurika Yamauchi 1, Taro Takami 1, Tomokazu Kawaoka 3, Shinsuke Uchikawa 3, Akira Hiramatsu 3, Hiroshi Aikata 3, Reo Kawano 4, Kazufumi Kobayashi 5 6, Takayuki Kondo 5, Sadahisa Ogasawara 5 6, Tetsuhiro Chiba 5, Kazuaki Chayama 3, Naoya Kato 5, Isao Sakaida 1
|
|
| |
| 182. | Sustained Complete Response after Biological Downstaging in Patients with Hepatocellular Carcinoma: XXL-Like Prioritization for Liver Transplantation or "Wait and See" Strategy? |
| |
Cancers (Basel). 2021 May 17;13(10):2406. doi: 10.3390/cancers13102406.
Alessandro Vitale 1, Federica Scolari 1, Alessandra Bertacco 1, Enrico Gringeri 1, Francesco D'Amico 1, Domenico Bassi 1, Francesco Enrico D'Amico 1, Paolo Angeli 2, Patrizia Burra 3, Quirino Lai 4, Umberto Cillo 1
|
|
| |
|
|
| |
| 184. | Liver Transplantation for Hepatocellular Carcinoma: A Real-Life Comparison of Milan Criteria and AFP Model |
| |
Cancers (Basel). 2021 May 19;13(10):2480. doi: 10.3390/cancers13102480.
Bleuenn Brusset 1 2, Jerome Dumortier 3, Daniel Cherqui 4, Georges-Philippe Pageaux 5, Emmanuel Boleslawski 6, Ludivine Chapron 2, Jean-Louis Quesada 2, Sylvie Radenne 7, Didier Samuel 4, Francis Navarro 5, Sebastien Dharancy 6, Thomas Decaens 1 2 8
|
|
| |
| 185. | The Hepatic Innovation Team Collaborative: A Successful Population-Based Approach to Hepatocellular Carcinoma Surveillance |
| |
Cancers (Basel). 2021 May 7;13(9):2251. doi: 10.3390/cancers13092251.
Shari S Rogal 1 2, Vera Yakovchenko 3, Rachel Gonzalez 4, Angela Park 5, Lauren A Beste 6 7, Karine Rozenberg-Ben-Dror 8, Jasmohan S Bajaj 9 10, Dawn Scott 11, Heather McCurdy 12, Emily Comstock 13, Michael Sidorovic 14, Sandra Gibson 1, Carolyn Lamorte 1, Anna Nobbe 15, Maggie Chartier 16, David Ross 16, Jason A Dominitz 17 18, Timothy R Morgan 19 20
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 191. | Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology |
| |
J Natl Compr Canc Netw. 2021 May 1;19(5):541-565. doi: 10.6004/jnccn.2021.0022.
Al B Benson 1, Michael I D'Angelica 2, Daniel E Abbott 3, Daniel A Anaya 4, Robert Anders 5, Chandrakanth Are 6, Melinda Bachini 7, Mitesh Borad 8, Daniel Brown 9, Adam Burgoyne 10, Prabhleen Chahal 11, Daniel T Chang 12, Jordan Cloyd 13, Anne M Covey 2, Evan S Glazer 14, Lipika Goyal 15, William G Hawkins 16, Renuka Iyer 17, Rojymon Jacob 18, R Kate Kelley 19, Robin Kim 20, Matthew Levine 21, Manisha Palta 22, James O Park 23, Steven Raman 24, Sanjay Reddy 25, Vaibhav Sahai 26, Tracey Schefter 27, Gagandeep Singh 28, Stacey Stein 29, Jean-Nicolas Vauthey 30, Alan P Venook 19, Adam Yopp 31, Nicole R McMillian 32, Cindy Hochstetler 32, Susan D Darlow 32
|
|
| |
|
|
| |
| 193. | SBRT for HCC: Overview of technique and treatment response assessment |
| |
Abdom Radiol (NY). 2021 May 7. doi: 10.1007/s00261-021-03107-7.Online ahead of print.
Kimberly L Shampain 1, Caitlin E Hackett 2, Sohrab Towfighi 3, Anum Aslam 2, William R Masch 2, Alison C Harris 3, Silvia D Chang 3, Kanika Khanna 4, Vivek Mendiratta 4, Ahmed M Gabr 5, Dawn Owen 6, Mishal Mendiratta-Lala 2
|
|
| |
| 194. | The predictive value of tumor infiltrating leukocytes in Hepatocellular Carcinoma: A systematic review and meta-analysis |
| |
Eur J Surg Oncol. 2021 May 4;S0748-7983(21)00473-X. doi: 10.1016/j.ejso.2021.04.042.Online ahead of print.
Markus Bo Schoenberg 1, Xiaokang Li 2, Xinyu Li 2, Yongsheng Han 2, Jingcheng Hao 3, Rainer Christoph Miksch 2, Dominik Koch 2, Nikolaus Börner 2, Nicola Theresa Beger 2, Julian Nikolaus Bucher 2, Tobias Simon Schiergens 2, Markus Otto Guba 2, Jens Werner 1, Alexandr V Bazhin 4
|
|
| |
|
|
| |
|
|
| |
| 197. | African Immigrants in New York City with Hepatitis B-Related Hepatocellular Carcinoma Demonstrate High Morbidity and Mortality |
| |
J Immigr Minor Health. 2021 Apr 27. doi: 10.1007/s10903-021-01205-8. Online ahead of print.
Jacquelyn Carr 1, Da Eun Cha 1, Tali Shaltiel 1, Serena Zheng 1, Cleo Siderides 1, Benjamin Golas 1, Daniel Labow 1, Deepa Magge 1, Noah Cohen 1, Andrea Branch 2, Umut Sarpel 3
|
|
| |
| 198. | Long-term evolution of LI-RADS observations in HCV-related cirrhosis treated with direct-acting antivirals |
| |
Liver Int. 2021 Apr 28. doi: 10.1111/liv.14914. Online ahead of print.
Roberto Cannella 1 2, Federica Vernuccio 1 2 3 4, Ciro Celsa 2 5, Giuseppe Cabibbo 2, Vincenza Calvaruso 2, Silvia Greco 1, Salvatore Battaglia 6, Kingshuk Roy Choudhury 7, An Tang 8, Massimo Midiri 1, Vito Di Marco 2, Calogero Cammà 2, Giuseppe Brancatelli 1
|
|
| |
|
|
| |
|
|
| |
| 201. | Aspirin in hepatocellular carcinoma |
| |
Cancer Res. 2021 Apr 23;canres.0758.2021. doi: 10.1158/0008-5472.CAN-21-0758.Online ahead of print.
Emanuela Ricciotti 1, Kirk J Wangensteen 2, Garret A FitzGerald 3
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 207. | How to Treat Hepatocellular Carcinoma in Elderly Patients |
| |
Pharmaceuticals (Basel). 2021 Mar 8;14(3):233. doi: 10.3390/ph14030233.
Piera Federico 1, Emilio Francesco Giunta 1 2, Annalisa Pappalardo 1 2, Andrea Tufo 3, Gianpaolo Marte 3, Laura Attademo 1, Antonietta Fabbrocini 1, Angelica Petrillo 1 2, Bruno Daniele 1
|
|
| |
| 208. | Hepatocellular carcinoma: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, AFEF, SIAD, SFR/FRI) |
| |
Clin Res Hepatol Gastroenterol. 2021 Mar 26;45(2):101590.doi: 10.1016/j.clinre.2020.101590. Online ahead of print.
Jean Frédéric Blanc 1, Audrey Debaillon-Vesque 2, Gaël Roth 3, Jean Claude Barbare 4, Anne Sophie Baumann 5, Valérie Boige 6, Karim Boudjema 7, Mohamed Bouattour 8, Gilles Crehange 9, Barbara Dauvois 10, Thomas Decaens 3, François Dewaele 11, Olivier Farges 8, Boris Guiu 12, Antoine Hollebecque 6, Philippe Merle 13, Janick Selves 14, Thomas Aparicio 15, Isaac Ruiz 16, Olivier Bouché 17, Thésaurus National de Cancérologie Digestive (TNCD); Société Nationale Française de Gastroentérologie (SNFGE); Fédération Francophone de Cancérologie Digestive (FFCD); Groupe Coopérateur multidisciplinaire en Oncologie (GERCOR); Fédération Nationale des Centres de Lutte Contre le Cancer (UNICANCER); Société Française de Chirurgie Digestive (SFCD); Société Française d’Endoscopie Digestive (SFED); Société Française de Radiothérapie Oncologique (SFRO); Association Française pour l’Etude du Foie (AFEF)
|
|
| |
| 209. | Artificial intelligence in assessment of hepatocellular carcinoma treatment response |
| |
Abdom Radiol (NY). 2021 Mar 31. doi: 10.1007/s00261-021-03056-1.Online ahead of print.
Bradley Spieler 1, Carl Sabottke 2, Ahmed W Moawad 3, Ahmed M Gabr 4, Mustafa R Bashir 5, Richard Kinh Gian Do 6, Vahid Yaghmai 7, Radu Rozenberg 8, Marielia Gerena 9, Joseph Yacoub 10, Khaled M Elsayes 11
|
|
| |
|
|
| |
| 211. | Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort |
| |
J Hepatol. 2021 Mar 18;S0168-8278(21)00176-8. doi: 10.1016/j.jhep.2021.02.034.Online ahead of print.
Stephen A Harrison 1, Samer Gawrieh 2, Katharine Roberts 3, Christopher J Lisanti 4, Ryan B Schwope 4, Katherine M Cebe 5, Valerie Paradis 6, Pierre Bedossa 6, Jennifer M Aldridge Whitehead 7, Aymeric Labourdette 8, Véronique Miette 8, Stefan Neubauer 9, Céline Fournier 10, Angelo H Paredes 3, Naim Alkhouri 11
|
|
| |
| 212. | NAFLD and MAFLD as emerging causes of HCC: A populational study |
| |
JHEP Rep. 2021 Jan 19;3(2):100231. doi: 10.1016/j.jhepr.2021.100231. eCollection 2021 Apr.
Shuna Myers 1, Isabelle Neyroud-Caspar 2, Laurent Spahr 3, Konstantinos Gkouvatsos 3, Evelyne Fournier 2, Emiliano Giostra 3, Giulia Magini 3 4, Jean-Louis Frossard 3, Marie-Eve Bascaron 5, Nathalie Vernaz 6, Lucia Zampaglione 3, Francesco Negro 3 7, Nicolas Goossens 3 8
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 217. | Retrospective-Prospective Study of Safety and Efficacy of Sofosbuvir based Direct Acting Antivirals in HIV/HCV Coinfected Participants with Decompensated Liver Disease Pre or Post Liver Transplant |
| |
Am J Transplant. 2020 Dec 4. doi: 10.1111/ajt.16427. Online ahead of print.
Marion G Peters 1, Shyam Kottilil 2, Norah Terrault 3, Dominic Amara 4, Jennifer Husson 2, Shirish Huprikar 5, Sander Florman 6, Mark S Sulkowski 7, Christine M Durand 7, Anne F Luetkemeyer 1, Rodney Rogers 4, Joshua Grab 1, Brandy Haydel 6, Emily Blumberg 8, Lorna Dove 9, Jean Emond 10, Kim Olthoff 11, Coleman Smith 12, Thomas Fishbein 12, Henry Masur 13, Peter G Stock 4
|
|
| |
| 218. | Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis |
| |
Cancers (Basel). 2021 Feb 15;13(4):812. doi: 10.3390/cancers13040812.
Gaël S Roth 1 2 3, Maxime Benhamou 4, Yann Teyssier 1 5, Arnaud Seigneurin 1 6, Mélodie Abousalihac 1 2, Christian Sengel 5, Olivier Seror 4 7 8, Julien Ghelfi 1 3 5, Nathalie Ganne-Carrié 7 8 9, Lorraine Blaise 9, Olivier Sutter 4, Thomas Decaens 1 2 3, Jean-Charles Nault 7 8 9
|
|
| |
| 219. | Elevated Glycated Hemoglobin Is Associated With Liver Fibrosis, as Assessed by Elastography, in a Population-Based Study of Mexican Americans |
| |
Hepatol Commun. 2020 Oct 31;4(12):1793-1801. doi: 10.1002/hep4.1603. eCollection 2020 Dec.
Gordon P Watt 1, Isela De La Cerda 2, Jen-Jung Pan 3, Michael B Fallon 4, Laura Beretta 5, Rohit Loomba 6, Miryoung Lee 2, Joseph B McCormick 2, Susan P Fisher-Hoch 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 228. | Hepatocellular carcinoma |
| |
Nat Rev Dis Primers. 2021 Jan 21;7(1):6. doi: 10.1038/s41572-020-00240-3.
Josep M Llovet 1 2 3, Robin Kate Kelley 4, Augusto Villanueva 5, Amit G Singal 6, Eli Pikarsky 7, Sasan Roayaie 8, Riccardo Lencioni 9 10, Kazuhiko Koike 11, Jessica Zucman-Rossi 12 13, Richard S Finn 14
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 234. | Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes |
| |
Surg Oncol. 2020 Dec 30;36:138-146. doi: 10.1016/j.suronc.2020.12.011. Online ahead of print.
Phillip M Kemp Bohan 1, Anne E O'Shea 1, Andrew J Lee 2, Robert C Chick 1, Timothy E Newhook 3, Hop S Tran Cao 3, Casey J Allen 3, Daniel W Nelson 4, G Travis Clifton 1, Jean-Nicolas Vauthey 3, Ching-Wei D Tzeng 3, Timothy J Vreeland 5
|
|
| |
|
|
| |
| 236. | Namodenoson in Advanced Hepatocellular Carcinoma and Child-Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial |
| |
Cancers (Basel). 2021 Jan 7;13(2):E187. doi: 10.3390/cancers13020187.
Salomon M Stemmer 1, Nebojsa S Manojlovic 2, Mihai Vasile Marinca 3, Petar Petrov 4, Nelly Cherciu 5, Doina Ganea 6, Tudor Eliade Ciuleanu 7, Ioana Adriana Pusca 8, Muhammad Shaalan Beg 9, William T Purcell 10, Adina-Emilia Croitoru 11, Rumyana Nedyalkova Ilieva 12, Sladjana Natoševic 13, Amedeia Lavinir Nita 14, Dimitar Nikolaev Kalev 15, Zivit Harpaz 16, Motti Farbstein 16, Michael H Silverman 16, David Bristol 16, Inbal Itzhak 16, Pnina Fishman 16
|
|
| |
| 237. | Predicting survival after liver transplantation in patients with hepatocellular carcinoma using the LiTES-HCC score |
| |
J Hepatol. 2021 Jan 13;S0168-8278(21)00004-0. doi: 10.1016/j.jhep.2020.12.021.Online ahead of print.
David Goldberg 1, Alejandro Mantero 2, Craig Newcomb 3, Cindy Delgado 4, Kimberly A Forde 5, David E Kaplan 6, Binu John 7, Nadine Nuchovich 4, Barbara Dominguez 4, Ezekiel Emanuel 8, Peter P Reese 9
|
|
| |
|
|
| |
| 239. | Deep learning-assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver |
| |
Eur Radiol. 2021 Jan 6. doi: 10.1007/s00330-020-07559-1. Online ahead of print.
Paula M Oestmann 1 2 3, Clinton J Wang 1 4, Lynn J Savic 1 2, Charlie A Hamm 1 2, Sophie Stark 1 2 5, Isabel Schobert 1 2, Bernhard Gebauer 2, Todd Schlachter 1, MingDe Lin 1, Jeffrey C Weinreb 1, Ramesh Batra 6, David Mulligan 6, Xuchen Zhang 7, James S Duncan 1 4, Julius Chapiro 8
|
|
| |
|
|
| |
|
|
| |
| 242. | Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline |
| |
J Clin Oncol. 2020 Dec 20;38(36):4317-4345. doi: 10.1200/JCO.20.02672. Epub 2020 Nov 16.
John D Gordan 1, Erin B Kennedy 2, Ghassan K Abou-Alfa 3, Muhammad Shaalan Beg 4, Steven T Brower 5, Terence P Gade 6, Laura Goff 7, Shilpi Gupta 8, Jennifer Guy 9, William P Harris 10, Renuka Iyer 11, Ishmael Jaiyesimi 12, Minaxi Jhawer 13, Asha Karippot 14, Ahmed O Kaseb 15, R Kate Kelley 1, Jennifer J Knox 16, Jeremy Kortmansky 17, Andrea Leaf 18, William M Remak 19, Rachna T Shroff 20, Davendra P S Sohal 21, Tamar H Taddei 22, Neeta K Venepalli 23, Andrea Wilson 24, Andrew X Zhu 25, Michal G Rose 26
|
|
| |
|
|
| |
| 244. | Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C |
| |
Transplant Direct. 2020 Dec 8;7(1):e635. doi: 10.1097/TXD.0000000000001049.eCollection 2021 Jan.
Chung Sang Tse 1 2, Ju Dong Yang 3 4 5, Omar Y Mousa 6 7, Kevin M Nelson 6, Surakit Pungpapong 7, Andrew Keaveny 7, Bashar A Aqel 8, Hugo Vargas 8, Rolland C Dickson 8, Kymberly Watt 6, Gregory J Gores 6, Lewis R Roberts 6, Michael D Leise 6
|
|
| |
|
|
| |
| 246. | US-triggered Microbubble Destruction for Augmenting Hepatocellular Carcinoma Response to Transarterial Radioembolization: A Randomized Pilot Clinical Trial |
| |
Radiology. 2020 Dec 15;202321. doi: 10.1148/radiol.2020202321. Online ahead of print.
John R Eisenbrey 1, Flemming Forsberg 1, Corinne E Wessner 1, Lauren J Delaney 1, Kristen Bradigan 1, Sriharsha Gummadi 1, Mohamed Tantawi 1, Andrej Lyshchik 1, Patrick O'Kane 1, Ji-Bin Liu 1, Charles Intenzo 1, Jesse Civan 1, Warren Maley 1, Scott W Keith 1, Kevin Anton 1, Allison Tan 1, Amanda Smolock 1, Susan Shamimi-Noori 1, Colette M Shaw 1
|
|
| |
|
|
| |
|
|
| |
| 249. | Strategies for the delay of surgery in the management of resectable hepatobiliary malignancies during the COVID-19 pandemic |
| |
Curr Oncol. 2020 Oct;27(5):e501-e511. doi: 10.3747/co.27.6785. Epub 2020 Oct 1.
S Bennett 1, K Søreide 2, S Gholami 3, P Pessaux 4, C Teh 5, E Segelov 6, H Kennecke 3, H Prenen 7, S Myrehaug 1, D Callegaro 1 8, J Hallet 1
|
|
| |
|
|
| |
|
|
| |
| 252. | ACR Appropriateness Criteria® Liver Lesion-Initial Characterization |
| |
Am Coll Radiol. 2020 Nov;17(11S):S429-S446.doi: 10.1016/j.jacr.2020.09.005.
Expert Panel on Gastrointestinal Imaging; Victoria Chernyak 1, Jeanne M Horowitz 2, Ihab R Kamel 3, Hina Arif-Tiwari 4, Mustafa R Bashir 5, Brooks D Cash 6, James Farrell 7, Alan Goldstein 8, Joseph R Grajo 9, Samir Gupta 10, Nicole M Hindman 11, Aya Kamaya 12, Michelle M McNamara 13, Kristin K Porter 13, Lilja Bjork Solnes 14, Pavan K Srivastava 15, Atif Zaheer 16, Laura R Carucci 17
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 256. | Getting to implementation: a protocol for a Hybrid III stepped wedge cluster randomized evaluation of using data-driven implementation strategies to improve cirrhosis care for Veterans |
| |
Implement Sci. 2020 Oct 21;15(1):92. doi: 10.1186/s13012-020-01050-7.
Shari S Rogal 1 2, Vera Yakovchenko 3, Timothy Morgan 4 5, Jasmohan S Bajaj 6 7, Rachel Gonzalez 8, Angela Park 9, Lauren Beste 10 11, Edward J Miech 12, Carolyn Lamorte 13, Brittney Neely 13, Sandra Gibson 13, Patrick S Malone 14, Maggie Chartier 15, Tamar Taddei 16 17, Guadalupe Garcia-Tsao 16 17, Byron J Powell 18, Jason A Dominitz 19 20, David Ross 15, Matthew J Chinman 13 21
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 261. | Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial |
| |
Thomas Yau 1, Yoon-Koo Kang 2, Tae-You Kim 3, Anthony B El-Khoueiry 4, Armando Santoro 5, Bruno Sangro 6, Ignacio Melero 7, Masatoshi Kudo 8, Ming-Mo Hou 9, Ana Matilla 10, Francesco Tovoli 11, Jennifer J Knox 12, Aiwu Ruth He 13, Bassel F El-Rayes 14, Mirelis Acosta-Rivera 15, Ho-Yeong Lim 16, Jaclyn Neely 17, Yun Shen 18, Tami Wisniewski 19, Jeffrey Anderson 19, Chiun Hsu 20
|
|
| |
| 262. | Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation |
| |
Health Technol Assess. 2020 Sep;24(48):1-264. doi: 10.3310/hta24480.
Matthew Walton 1, Ros Wade 1, Lindsay Claxton 1, Sahar Sharif-Hurst 1, Melissa Harden 1, Jai Patel 2, Ian Rowe 2, Robert Hodgson 1, Alison Eastwood 1
|
|
| |
| 263. | Real-World Effectiveness of Obeticholic Acid in Patients with Primary Biliary Cholangitis |
| |
Hepatol Commun. 2020 Jul 6;4(9):1332-1345. doi: 10.1002/hep4.1518. eCollection 2020 Sep.
Surain B Roberts 1 2, Marwa Ismail 1, Gowthami Kanagalingam 1, Andrew L Mason 3, Mark G Swain 4, Catherine Vincent 5, Eric M Yoshida 6, Cynthia Tsien 7, Jennifer A Flemming 8, Harry L A Janssen 1, Gideon M Hirschfield 1, Bettina E Hansen 1 2, Aliya F Gulamhusein 1 2, Canadian Network for Autoimmune Liver Disease
|
|
| |
| 264. | Short-term Safety and Quality of Life Outcomes Following Radioembolization in Primary and Secondary Liver Tumours: a Multi-centre Analysis of 200 Patients in France |
| |
Cardiovasc Intervent Radiol. 2020 Sep 25. doi: 10.1007/s00270-020-02643-x.Online ahead of print.
Romaric Loffroy 1, Maxime Ronot 2, Michel Greget 3, Antoine Bouvier 4, Charles Mastier 5, Christian Sengel 6, Lambros Tselikas 7, Dirk Arnold 8, Geert Maleux 9, Jean-Pierre Pelage 10, Olivier Pellerin 11, Bora Peynircioglu 12, Bruno Sangro 13, Niklaus Schaefer 14, María Urdániz 15, Nathalie Kaufmann 16, José Ignacio Bilbao 17, Thomas Helmberger 18, Valérie Vilgrain 2, CIRT-FR Principal Investigators
Collaborators
- CIRT-FR Principal Investigators:
Gilles Piana, Julien Frandon, Jean-Pierre Tasu, Hicham Kobeiter
|
|
| |
| 265. | Disparities in Presentation at Time of Hepatocellular Carcinoma Diagnosis: A United States Safety-Net Collaborative Study |
| |
Ann Surg Oncol. 2020 Sep 25. doi: 10.1245/s10434-020-09156-4. Online ahead of print.
Joshua P Kronenfeld 1, Emily L Ryon 1, David Goldberg 2, Rachel M Lee 3, Adam Yopp 4, Annie Wang 5, Ann Y Lee 5, Sommer Luu 6, Cary Hsu 6, Eric Silberfein 6, Maria C Russell 3, Alan S Livingstone 1, Nipun B Merchant 1, Neha Goel 7
|
|
| |
|
|
| |
|
|
| |
| 268. | Hepatitis B virus preS2?38-55 variants: A newly identified risk factor for hepatocellular carcinoma |
| |
JHEP Rep. 2020 Jul 11;2(5):100144. doi: 10.1016/j.jhepr.2020.100144. eCollection 2020 Oct.
Damien Cohen 1, Sumantra Ghosh 1, Yusuke Shimakawa 2, Njie Ramou 3, Pierre Simon Garcia 4 5, Anaëlle Dubois 1, Clément Guillot 1, Nora Kakwata-Nkor Deluce 1, Valentin Tilloy 6, Geoffroy Durand 3, Catherine Voegele 3, Gibril Ndow 7, Umberto d'Alessandro 7, Céline Brochier-Armanet 4, Sophie Alain 6, Florence Le Calvez-Kelm 3, Janet Hall 1, Fabien Zoulim 1 8, Maimuna Mendy 3, Mark Thursz 9, Maud Lemoine 9, Isabelle Chemin 1
|
|
| |
| 269. | SIRT Compared with DEB-TACE for Hepatocellular Carcinoma: a Real-world Study (the SITAR Study) |
| |
J Gastrointest Cancer. 2020 Sep 9. doi: 10.1007/s12029-020-00502-z. Online ahead of print.
Ryan D Hirsch 1 2, Chris Mills 3, Rohit Sawhney 4 5, Siddharth Sood 6, Virginia Bird 6, Gauri Mishra 7, Anouk Dev 7, William Kemp 8 9, John Lubel 8 9, Stuart K Roberts 8 9, Paul Gow 3, Amanda J Nicoll 4 5 6
|
|
| |
|
|
| |
| 271. | Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial |
| |
ESMO Open. 2020 Aug;5(4):e000714. doi: 10.1136/esmoopen-2020-000714.
Robin Kate Kelley 1, Baek-Yeol Ryoo 2, Philippe Merle 3, Joong-Won Park 4, Luigi Bolondi 5, Stephen L Chan 6, Ho Yeong Lim 7, Ari D Baron 8, Francis Parnis 9, Jennifer Knox 10, Stéphane Cattan 11, Thomas Yau 12, Julie C Lougheed 13, Steven Milwee 14, Anthony B El-Khoueiry 15, Ann-Lii Cheng 16, Tim Meyer 17, Ghassan K Abou-Alfa 18 19
|
|
| |
| 272. | Individualized adaptive radiation therapy allows for safe treatment of hepatocellular carcinoma in patients with Child-Turcotte-Pugh B liver disease |
| |
Int J Radiat Oncol Biol Phys. 2020 Aug 24;S0360-3016(20)34141-9.doi: 10.1016/j.ijrobp.2020.08.046. Online ahead of print.
William C Jackson 1, Ming Tang 2, Christopher Maurino 2, Mishal Mendiratta-Lala 3, Neehar D Parikh 4, Martha M Matuszak 2, Janell S Dow 2, Yue Cao 2, Charles S Mayo 2, Randall K Ten Haken 2, Matthew J Schipper 2, Kyle C Cuneo 2, Dawn Owen 2, Theodore S Lawrence 2
|
|
| |
|
|
| |
| 274. | Effects of Metformin Exposure on Survival in a Large National Cohort of Patients with Diabetes and Cirrhosis |
| |
Clin Gastroenterol Hepatol. 2020 Aug 13;S1542-3565(20)31135-6.doi: 10.1016/j.cgh.2020.08.026. Online ahead of print.
David E Kaplan 1, Marina Serper 2, Binu V John 3, Kristen M Tessiatore 4, Renata Lerer 4, Rajni Mehta 5, Rena Fox 6, Ayse Aytaman 7, Michelle Baytarian 8, Kristel Hunt 9, Jeffrey Albrecht 10, Tamar H Taddei 5, VOCAL Study Group
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 278. | Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma |
| |
J Clin Oncol. 2020 Jul 27;JCO2000808. doi: 10.1200/JCO.20.00808. Online ahead of print.
Richard S Finn 1, Masafumi Ikeda 2, Andrew X Zhu 3 4, Max W Sung 5, Ari D Baron 6, Masatoshi Kudo 7, Takuji Okusaka 8, Masahiro Kobayashi 9, Hiromitsu Kumada 9, Shuichi Kaneko 10, Marc Pracht 11, Konstantin Mamontov 12, Tim Meyer 13, Tomoki Kubota 14, Corina E Dutcus 15, Kenichi Saito 15, Abby B Siegel 16, Leonid Dubrovsky 16, Kalgi Mody 15, Josep M Llovet 17 18
|
|
| |
| 279. | A Pilot Trial Evaluating Stereotactic Body Radiation Therapy to Induce Hyperemia in Combination with Transarterial Chemoembolization for Hepatocellular Carcinoma |
| |
Int J Radiat Oncol Biol Phys. 2020 Jul 23;S0360-3016(20)31452-8.doi: 10.1016/j.ijrobp.2020.07.033. Online ahead of print.
Nikhil T Sebastian 1, Eric D Miller 1, Xiangyu Yang 2, Dayssy Alexandra Diaz 1, Yubo Tan 3, Joshua Dowell 2, James Spain 2, Ali Rikabi 2, Eric Elliott 2, Michael Knopp 2, Terence M Williams 4
|
|
| |
|
|
| |
| 281. | Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells |
| |
J Precis Oncol. 2020 Jul 2;4:16. doi: 10.1038/s41698-020-0123-0. eCollection 2020.
Colin M Court 1 2 3, Shuang Hou 1, Lian Liu 4, Paul Winograd 1 2, Benjamin J DiPardo 1 2, Sean X Liu 5, Pin-Jung Chen 5, Yazhen Zhu 5, Matthew Smalley 5, Ryan Zhang 5, Saeed Sadeghi 6, Richard S Finn 6, Fady M Kaldas 1, Ronald W Busuttil 1 7, Xianghong J Zhou 8, Hsian-Rong Tseng 5 7 9, James S Tomlinson 1 2 9, Thomas G Graeber 3 5 7 9, Vatche G Agopian 1 9
|
|
| |
| 282. | Serum alpha-fetoprotein levels and clinical outcome in the phase 3 CELESTIAL study of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma |
| |
Clin Cancer Res. 2020 Jul 7;clincanres.3884.2019. doi: 10.1158/1078-0432.CCR-19-3884.Online ahead of print.
Robin K Kelley 1, Tim Meyer 2, Lorenza Rimassa 3, Philippe Merle 4, Joong-Won Park 5, Thomas Yau 6, Stephen L Chan 7, Jean-Frederic Blanc 8, Vincent C Tam 9, Albert Tran 10, Vincenzo Dadduzio 11, David W Markby 12, Rajesh Kaldate 13, Ann-Lii Cheng 14, Anthony B El-Khoueiry 15, Ghassan K Abou-Alfa 16
|
|
| |
| 283. | Non-invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh Type 2 Diabetes Study |
| |
Liver Int. 2020 Jul 7. doi: 10.1111/liv.14590. Online ahead of print.
Sheila M Grecian 1, Stela McLachlan 1, Jonathan A Fallowfield 2, Patrick Ka Kearns 3, Peter C Hayes 2, Indra Neil Guha 4, Joanne R Morling 1, Stephen Glancy 5, Rachel M Williamson 6, Rebecca M Reynolds 7, Brian M Frier 7, Nicola N Zammitt 8, Jackie F Price 1, Mark Wj Strachan 6
|
|
| |
|
|
| |
|
|
| |
| 286. | AFP Ratio Predicts HCC Recurrence After Liver Transplantation |
| |
PLoS One. 2020 Jul 2;15(7):e0235576. doi: 10.1371/journal.pone.0235576. eCollection 2020.
Christine Koch 1, Theresa Bette 1, Oliver Waidmann 1, Natalie Filmann 2, Christopher Schrecker 1, Jörg Trojan 1, Nina Weiler 1, Johannes Vermehren 1, Andreas A Schnitzbauer 3, Wolf Otto Bechstein 3, Stefan Zeuzem 1, Eva Herrmann 2, Martin-Walter Welker 1
|
|
| |
|
|
| |
| 288. | Hepatocellular Carcinoma in Patients With No Identifiable Risk Factors |
| |
(Oxford). 2020 Jun 23;S1365-182X(20)31020-0. doi: 10.1016/j.hpb.2020.05.005.Online ahead of print.
Caitlin A McIntyre 1, Joanne F Chou 2, Mithat Gonen 2, Jinru Shia 3, Maya Gambarin-Gelwan 4, Vinod P Balachandran 1, T Peter Kingham 1, Peter J Allen 1, Jeffrey A Drebin 1, William R Jarnagin 1, Michael I D'Angelica 5
|
|
| |
| | | | |
